Debra Frimerman Takes Leadership as Chief Legal Officer
Pivot Bio, one of the premier innovative agtech companies, has announced the appointment of Debra Frimerman as the new chief legal officer. She steps into this vital role during a period of growth for the company and after the departure of General Counsel Devang Shah, who is pursuing a new opportunity.
Strategic Guidance in Legal and Compliance
Frimerman comes with over two decades of experience in legal affairs and strategic business development. In her new role, she will manage Pivot Bio's legal, compliance, and governance functions, effectively steering the company through its growth in North America and its global expansion initiatives. An essential part of her responsibilities will be safeguarding Pivot Bio's robust patent portfolio.
Vision for Continued Growth
As part of the executive leadership team, Frimerman will report directly to Chief Executive Officer Chris Abbott. Abbott expressed his confidence in Frimerman by stating, "Debra is a trusted leader who understands both the letter of the law and the ambitions of a high-growth, science-driven company." He highlighted her experience with complex transactions and forming strategic partnerships as key attributes that make her perfect for the role at this pivotal time for Pivot Bio.
A Proven Track Record
Before taking on the chief legal officer position, Frimerman significantly contributed to Pivot Bio’s growth as the chief business development officer. There, she facilitated new revenue streams, negotiated impactful partnerships, and strategically positioned the company for future success.
Prior Experience in Major Firms
Frimerman's prior role as general counsel, corporate secretary, and chief compliance officer at Calyxt showcased her leadership skills where she oversaw legal, licensing, and intellectual property matters. She led a successful series of mergers between Calyxt and Cibus, resulting in a company valuation exceeding $650 million. Her career also includes serving as associate general counsel at Syngenta, where she was instrumental in global technology licensing within Syngenta Seeds.
Throughout her career, Frimerman has advised on various public and private securities offerings, successfully raising over $1 billion. She began her legal journey as a corporate attorney at prestigious firms and holds a JD from the University of Minnesota, graduating magna cum laude, along with a BA in economics from the University of California, Santa Barbara.
About Pivot Bio
Pivot Bio is recognized as a leader in agtech innovation, delivering sustainable crop nutrition technologies that leverage nature to help farmers meet the growing demand for food. With a commitment to addressing agricultural challenges, Pivot Bio's solutions are now available in North America and are set to expand into Brazil.
The company specializes in groundbreaking innovations that are acknowledged among the agriculture industry's most promising climate solutions. It has received multiple accolades from TIME magazine for its contributions to technology and sustainability, alongside recognitions from various reputable industry lists for being innovative and impactful.
Frequently Asked Questions
What is the role of Debra Frimerman at Pivot Bio?
Debra Frimerman serves as the Chief Legal Officer, overseeing legal, compliance, and governance functions.
What experience does Debra Frimerman bring to Pivot Bio?
Frimerman has over 20 years of legal and business development experience, including prior roles as chief business development officer at Pivot Bio.
What is Pivot Bio’s main focus in agriculture?
Pivot Bio develops sustainable crop nutrition technologies designed to meet the demands of farmers and the increasing global food requirement.
Where will Pivot Bio products soon be available?
Pivot Bio products are currently available in North America and will soon expand into Brazil.
Why is Debra Frimerman's appointment significant for Pivot Bio?
Her appointment is crucial as she brings extensive legal experience and strategic insight during a period of significant growth and expansion for Pivot Bio.
